Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric ABSSSI study of ceftaroline versus active comparator
2011-003812-22Phase 2
- Sponsor
- Cerexa
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ceftaroline fosamil in acute bacterial skin and skin structure infection (ABSSSI), Not applicable and bacterial disease (2 arms), sponsored by Cerexa. Primary endpoint: Safety assessments.
02
Drugs
ceftaroline fosamil
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)Not applicablebacterial disease
Beyond the preview
Go deeper on 2011-003812-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003812-22.